CSL: Result 2016

The new flu vaccine business isn't yet profitable, but antibodies are flying off the shelves.

Ten years ago, CSL was famous for three things: volatile earnings, thin margins and pitiful returns on capital. You would be forgiven for thinking the CSL of today was an entirely different company.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles